Fonte: Journal of Hepatology. Nome do evento: The International Liver Congress. Unidade: FMRP
Assuntos: HEPATITE C, ANTIVIRAIS
ABNT
CHEINQUER, H. et al. New direct action antivirals containing regimes to treat patients with hepatitis C chronic infection: first results from a national real-world registry of the Brazilian Hepatology Society. Journal of Hepatology. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 18 nov. 2024. , 2017APA
Cheinquer, H., Coelho, H. S., Aires, R. S., Quintela, E. D., Lobato, C., Filho, J. E. M., et al. (2017). New direct action antivirals containing regimes to treat patients with hepatitis C chronic infection: first results from a national real-world registry of the Brazilian Hepatology Society. Journal of Hepatology. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Cheinquer H, Coelho HS, Aires RS, Quintela ED, Lobato C, Filho JEM, Lima LB, Borba LA, Pessoa MG, Silva GF, Martinelli A de LC. New direct action antivirals containing regimes to treat patients with hepatitis C chronic infection: first results from a national real-world registry of the Brazilian Hepatology Society. Journal of Hepatology. 2017 ; 66 S508.[citado 2024 nov. 18 ]Vancouver
Cheinquer H, Coelho HS, Aires RS, Quintela ED, Lobato C, Filho JEM, Lima LB, Borba LA, Pessoa MG, Silva GF, Martinelli A de LC. New direct action antivirals containing regimes to treat patients with hepatitis C chronic infection: first results from a national real-world registry of the Brazilian Hepatology Society. Journal of Hepatology. 2017 ; 66 S508.[citado 2024 nov. 18 ]